Faculty Opinions recommendation of Safety and tolerability of an anti-CD19 monoclonal antibody, MEDI-551, in subjects with systemic sclerosis: a phase I, randomized, placebo-controlled, escalating single-dose study.

2017 ◽  
Author(s):  
Martin Aringer
Keyword(s):  
Monoclonal Antibody ◽  
Single Dose ◽  
Systemic Sclerosis ◽  
Phase I ◽  
Single Dose Study ◽  
Dose Study

A phase I ascending single-dose study of the safety, tolerability, and pharmacokinetics of bosutinib (SKI-606) in healthy adult subjects

2011 ◽  
Vol 69 (1) ◽  
pp. 221-227 ◽  
Author(s):  
Richat Abbas ◽  
Bruce A. Hug ◽  
Cathie Leister ◽  
Myriam El Gaaloul ◽  
Stephan Chalon ◽  
...  
Keyword(s):  
Single Dose ◽  
Phase I ◽  
Healthy Adult ◽  
Single Dose Study ◽  
Dose Study

Intravenous Cadi-05: Phase I single dose study

2008 ◽  
Vol 26 (15_suppl) ◽  
pp. 14019-14019
Author(s):  
M. C. Pant ◽  
V. Varma
Keyword(s):  
Single Dose ◽  
Phase I ◽  
Single Dose Study ◽  
Dose Study

scholarly journals Phase I single-dose study of intracavitary-administered Nimotuzumab labeled with 188-Re in adult recurrent high-grade glioma

2008 ◽  
Vol 7 (3) ◽  
pp. 333-339 ◽  
Author(s):  
Angel Casaco ◽  
Gerardo López ◽  
Iván García ◽  
José Arsenio Rodríguez ◽  
Ramsés Fernández ◽  
...  
Keyword(s):  
Single Dose ◽  
Phase I ◽  
High Grade Glioma ◽  
High Grade ◽  
Single Dose Study ◽  
Dose Study

Phase I Study of Ceftizoxime, a New Cephalosporin. Single-Dose Study

1981 ◽  
Vol 21 (10) ◽  
pp. 388-395 ◽  
Author(s):  
N. NAKASHIMA ◽  
K. SUZUKI ◽  
H. HASHIMOTO ◽  
K. NISHIJIMA
Keyword(s):  
Single Dose ◽  
Phase I ◽  
Phase I Study ◽  
Single Dose Study ◽  
Dose Study
Sign in / Sign up

Export Citation Format

Share Document